Aptitude Health

10/15/2026

Read more about Q3 2026 and , including 34 new or expanded indications for treatments targeting a range of tumor types and 7 new agents:

Aptitude Health’s quarterly recap of FDA- and EMA-approved oncology agents for 2026: 7 new agents and 34 new indications for existing treatments were approved in Q3

10/14/2026

Are you and your team challenged with understanding what is really happening inside specific health systems?​

OncoJourney helps life science teams move beyond data alone by combining system-specific real-world data with on-site clinician interpretation in multidisciplinary sessions to surface the true “why” behind oncology patient journey variation and then converts data into aligned action within a health system.​

Learn more about how OncoJourney can support your oncology strategy: https://www.aptitudehealth.com/real-world-evidence/oncojourney/?utm_source=Ads&utm_medium=LinkedIn&utm_campaign=OncoJourney

10/13/2026

The Global Leukemia Academy – is a 3-hour interactive webinar, delivering expert perspectives, updates on current data, and real-world case discussions focused on practical decision-making in adult acute lymphoblastic leukemia (ALL) care from the European region.

📅 23 November 2026 • Virtual Program​

Chair: Elias Jabbour, MD | MD Anderson Cancer Center, US​

Faculty:
· Josep-Maria Ribera, MD, PhD | Catalan Institute of Oncology, Spain​
· Nicolas Boissel, MD, PhD | Saint-Louis Hospital, France​
· Nicola Gökbuget, MD | University Hospital Frankfurt, Germany​

🔗 Register today: https://globalleukemiaacademy.com/treating-acute-leukemias-in-europe-nov-2026/?utm_source=Social&utm_medium=Post

10/08/2026

What can oncology leaders learn when community providers and KOLs review real patient cases together?

DECODE report sessions bring together highly influential community HCPs and leading KOL experts for moderated clinical discussions that reveal real-world treatment perspectives, practice patterns, and emerging trends.

Featured reports:​

ADCs in R/R Multiple Myeloma, Bispecific Antibodies in R/R Multiple Myeloma, CELMoDs in R/R Multiple Myeloma, CML, DLBCL, DTC, ER+ Breast Cancer, GEJ, ITP, LR-MDS, Multiple Myeloma, NSCLC, Ovarian Cancer, R/R DLBCL, SM​

Learn about the DECODE reports and how our business intelligence solutions can support your oncology strategy: https://www.aptitudehealth.com/business-intelligence/?utm_source=Social&utm_medium=Post

10/07/2026

Explore how community oncologists approach today's most challenging disease states at the CASES Northeast Summit, November 20–21 in Boston, MA.​​

This closed-door event features expert perspectives across complex tumor types. Featured reports:​​

aEC, Breast Cancer, CLL, CML, CRC, ITP, Lung Cancer, MF, Multiple Myeloma, Pancreatic Cancer, Prostate Cancer​

Purchase the report and silently observe real-world decision-making from community oncologists and hematologists as they share local treatment trends and reactions to emerging data.​​
​
Reserve your report: https://www.aptitudehealth.com/oncology-reports/?utm_source=Social&utm_medium=Post

10/06/2026

Aptitude Health continues to expand access to high-priority community oncology practices through the growth of our Axess Network, with a total of 208 in our network in Q3 2026.

These newly added practices represent meaningful opportunities for life science teams to engage community oncologists and hematologists through Aptitude Health’s Business Intelligence reports, delivering real-world insights from markets that matter most.

Contact us to learn more: https://www.aptitudehealth.com/contact-us/?utm_source=Post&utm_medium=Facebook

10/02/2026

Breast cancer is the most common cancer among women worldwide,¹ and approximately 1 in 8 women in the US will develop invasive breast cancer during their lifetime.²​

During Breast Cancer Awareness Month, Aptitude Health honors the strength of patients and is proud to support health care professionals and advocates whose dedication helps advance awareness, research, and care.​

1. https://www.bcrf.org/breast-cancer-statistics-and-resources/​
2. https://www.breastcancer.org/facts-statistics​

09/30/2026

Turn regional and national physician feedback into actionable oncology insights with CARE Reports.​

Aptitude Health gathers insights through expert-guided discussions and live polling from community physician audiences on a particular disease state, and CARE reports turn those findings into benchmarks that clarify community treatment patterns.

Learn how our business intelligence solutions can support your oncology strategy: ​‌ https://www.aptitudehealth.com/business-intelligence/?utm_source=Social&utm_medium=Post

09/29/2026

OncoGauge reports are derived from a new survey tool designed to help life science teams capture rapid feedback from oncology clinicians through the Aptitude Health Axess Network.

Learn how our business intelligence solutions can support your oncology strategy: https://www.aptitudehealth.com/business-intelligence/?utm_source=Social&utm_medium=Post

09/24/2026

Real-world evidence is about more than data. It's about understanding what happens in everyday clinical practice to provide stakeholders with insights they can utilize to make more informed and personalized cancer treatment decisions for their patients.​

As a senior data scientist at Aptitude Health, Misha Hoskins helps bridge the gap between clinical research and real-world patient care by applying rigorous analytics to better understand treatment decisions and outcomes across broader patient populations.​

We're grateful for Misha's expertise, curiosity, and commitment to advancing evidence-based insights in oncology and hematology.